Johnson & John…
ProfileJobs (2.17 k)

Johnson & Johnson

Suggest Edit
    • HealthcareManufacturing & Industrialconglomeratesconsumer chemistryconsumer goodshealth & beautymedical devicespharma

    Johnson & Johnson engages in the research and development, manufacture and sale of a range of products in the healthcare field. The Company is organized into three business segments: Consumer, Pharmaceutical and Medical Devices. The Consumer segment includes a broad range of products used in the baby care, oral care, beauty, over-the-counter pharmaceutical, women’s health and wound care markets. The Pharmaceutical segment is focused on five therapeutic areas: immunology, infectious diseases and vaccines, neuroscience, oncology, and cardiovascular and metabolic diseases. The Medical Devices segment includes a broad range of products used in the orthopaedic, surgery, cardiovascular, diabetes care and vision care fields.

    Revenue(FY, 2017)
    $76.5 B
    Market capitalization(2018-09-18)
    $377 B
    TypePublic
    HQNew Brunswick, US
    Founded1886
    Size (employees)134,000 (est)+7%
    Websitejnj.com
    Johnson & Johnson was founded in 1886 and is headquartered in New Brunswick, US
    Report incorrect company information

    Viewing summary data as a guest

    Sign up for free to see all data

    Key People/Management at Johnson & Johnson

    Alex Gorsky

    Alex Gorsky

    Chairman, Board of Directors and Chief Executive Officer
    Dominic J. Caruso

    Dominic J. Caruso

    Executive Vice President, Chief Financial Officer
    Joaquin Duato

    Joaquin Duato

    Executive Vice President and Worldwide Chairman, Pharmaceuticals
    Ashley McEvoy

    Ashley McEvoy

    Company Group Chairman, Consumer Medical Devices
    Jorge Mesquita

    Jorge Mesquita

    Executive Vice President, Worldwide Chairman, Consumer
    Sandra E. Peterson

    Sandra E. Peterson

    Group Worldwide Chair
    Show more

    Johnson & Johnson Office Locations

    Johnson & Johnson has offices in Caracas, Montevideo, Minsk, Almaty and in 50 other locations
    New Brunswick, US (HQ)
    One Johnson & Johnson Plaza
    Greenville, US
    204 Greenville Blvd SW
    Buenos Aires, AR
    Mendoza 1259
    Yerevan, AM
    12 Martiros Saryan St, office 7
    Broadway, AU
    Locked Bag 5
    Minsk, BY
    70 Ulitsa Myasnikova 5th floor
    Show all (55)
    Report incorrect company information

    Johnson & Johnson Financials and Metrics

    Johnson & Johnson Revenue

    Embed Graph
    Johnson & Johnson's revenue was reported to be $76.45 b in FY, 2017 which is a 6.3% increase from the previous period.
    USD

    Revenue (Q2, 2019)

    		20.8 b

    Gross profit (Q2, 2019)

    		13.9 b

    Gross profit margin (Q2, 2019), %

    		66.7%

    Net income (Q2, 2019)

    		4 b

    Market capitalization (18-Sep-2018)

    		377 b

    Closing stock price (18-Sep-2018)

    		140.5

    Cash (1-Jul-2018)

    		17.6 b

    EV

    		391.5 b
    Johnson & Johnson's current market capitalization is $377 b.
    Annual
    USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

    Revenue

    		71.3 b74.3 b70.1 b71.9 b76.5 b

    Revenue growth, %

    		4%(6%)3%6%

    Cost of goods sold

    		22.3 b22.7 b21.5 b21.7 b25.4 b

    Gross profit

    		49 b51.6 b48.5 b50.2 b51.1 b
    Quarterly
    USDQ1, 2015Q2, 2015Q3, 2015Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019

    Revenue

    		17.4 b17.8 b17.1 b17.5 b18.5 b17.8 b17.8 b18.8 b19.7 b20 b20.8 b

    Cost of goods sold

    		5.3 b5.4 b5.2 b5.3 b5.3 b5.5 b5.4 b5.8 b6.9 b6.6 b6.9 b

    Gross profit

    		12.1 b12.4 b11.9 b12.2 b13.1 b12.3 b12.4 b13 b12.7 b13.4 b13.9 b

    Gross profit Margin, %

    		70%70%69%70%71%69%70%69%65%67%67%
    show all
    Annual
    USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

    Cash

    		20.9 b14.5 b13.7 b19 b17.8 b

    Accounts Receivable

    		11.7 b11 b10.7 b11.7 b13.5 b

    Prepaid Expenses

    		4 b3.5 b3 b3.3 b2.5 b

    Inventories

    		7.9 b8.2 b8.1 b8.1 b8.8 b
    Quarterly
    USDQ1, 2015Q2, 2015Q3, 2015Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019

    Cash

    		12 b10.6 b13.6 b13.9 b18.6 b18.2 b20.9 b12.6 b15.7 b14.6 b17.6 b

    Accounts Receivable

    		11.5 b12 b11.4 b11.4 b12.1 b11.8 b12.3 b13.3 b13.2 b14.2 b14.1 b

    Prepaid Expenses

    		3.7 b3.1 b3 b3.3 b3.1 b2.6 b2.8 b3 b2.9 b2.6 b2.6 b

    Inventories

    		8.1 b8.3 b8.2 b8.2 b8.5 b8.5 b8.9 b9.7 b9.5 b9 b8.8 b
    show all
    Annual
    USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

    Net Income

    		13.8 b16.3 b15.4 b16.5 b1.3 b

    Depreciation and Amortization

    		4.1 b3.9 b3.7 b3.8 b5.6 b

    Inventories

    		(622 m)(1.1 b)(449 m)(249 m)581 m

    Accounts Payable

    		1.8 b955 m(3 m)656 m2.7 b
    Quarterly
    USDQ1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019

    Net Income

    		4.3 b8.8 b12.2 b4.3 b8.5 b12.7 b4.4 b8.2 b12 b4.4 b8.3 b

    Depreciation and Amortization

    		895 m1.8 b2.7 b891 m1.8 b2.7 b912 m2.1 b3.8 b1.7 b3.5 b

    Inventories

    		(276 m)(537 m)(719 m)(190 m)(443 m)(408 m)(368 m)(421 m)(193 m)(322 m)(491 m)

    Accounts Payable

    		(2.5 b)(2.2 b)1.6 b(2.3 b)(1 b)(1.2 b)(2 b)(1.2 b)339 m(1.7 b)(49 m)
    show all
    USDY, 2018

    EV/CFO

    		40.4 x

    Debt/Equity

    		0.5 x

    Debt/Assets

    		0.2 x

    Financial Leverage

    		2.5 x
    Show all financial metrics

    Johnson & Johnson Operating Metrics

    FY, 2014FY, 2015FY, 2016FY, 2017

    Manufacturing Facilities

    		134 121 119 125

    Facilities

    		265 250 230 260

    Countries

    		60 60 60 60

    Discovery Projects

    		100 150
    Show all operating metrics

    Johnson & Johnson Acquisitions / Subsidiaries

    Acquired CompanyDateDeal Size
    Zarbee's Naturals (49)July 27, 2018
    Actelion Pharmaceuticals (2 k)January 26, 2017$30 b
    Abott Medical Optics September 16, 2016$4.33 b
    Vogue International June 02, 2016$3.30 b
    Novira Therapeutics November 08, 2015
    XO1 March 20, 2015
    Alios BioPharma September 30, 2014$1.75 b
    Aragon Pharmaceuticals June 17, 2013$1 b
    Acclarent
    Advanced Sterilization Products Services Inc.
    Show more

    Johnson & Johnson Revenue Breakdown

    Embed Graph

    Johnson & Johnson revenue breakdown by business segment: 34.8% from Medical Devices, 47.4% from Pharmaceutical and 17.8% from Consumer

    Report incorrect company information

    Competitors

    Bayer
    Healthcare - Public
    Pfizer
    Healthcare - Public
    Procter & Gamble
    Healthcare - Public
    Unilever
    Food & Beverage - Public
    Colgate Palmolive
    Manufacturing & Industrial - Public
    Edgewell Personal Care
    Manufacturing & Industrial - Public
    Compare competitors

    Johnson & Johnson Online and Social Media Presence

    Embed Graph
    Report incorrect company information

    Johnson & Johnson News and Updates

    September 19, 2018

    Drug Delivery Systems 2018 Global Market Key Players – Novartis, Amgen, Roche, Pfizer, Johnson & Johnson, Becton Dickinson – Analysis and Forecast to 2025

    WiseGuyRerports.com Presents “Global Drug Delivery Systems Market Size, Status and Forecast 2018-2025” New Document to its Studies Database Posted via Industry Today. Follow us on Twitter @IndustryToday
    September 19, 2018

    Hospital Acquired Infection Treatment 2018 Global Market Key Players – Abbott, Pfizer, Bayer, Cepheid, AstraZeneca, Roche, Johnson & Johnson – Analysis and Forecast to 2025

    WiseGuyRerports.com Presents “Global Hospital Acquired Infection Treatment Market Size, Status and Forecast 2018-2025” New Document to its Studies Database Posted via Industry Today. Follow us on Twitter @IndustryToday
    September 17, 2018

    Increasing demand of Home-Care Monitoring And Diagnostics Market Analysis Report, Regional Outlook, Application Development Potential, Price Trends, Competitive Market Share & Forecast, 2025 key Players like Abbott Diagnostics,Johnson & Johnson, Roche Dia

    Home care monitoring and diagnostics devices predicted that the global home-care monitoring and diagnostics will witness fast-paced growth and post a CAGR of close to 10% during the forecast period. The rising disposable income level and recent improvements in living standards are some of the major …
    September 15, 2018

    Johnson & Johnson victims unhappy with panel set up to suggest compensation

    Aggrieved patients question impartiality of govt-appointed committee, call it 'one-sided'
    September 12, 2018

    Foot Care Products 2018 Global Market Key Players - Aetrex Worldwide Inc., Alva-Amco Pharmacals Inc., Dr Foot, Dreamyfeet Footcare Products, Foot Express, Johnson & Johnson......

    Foot Care Products – Global Market Demand, Growth, Opportunities, Manufacturers, Analysis of Top Key Players and Forecast to 2025 Posted via Industry Today. Follow us on Twitter @IndustryToday
    September 07, 2018

    Nanomedicines 2018 Global Market Key Players - Abbott, GE Healthcare, Johnson & Johnson, Merck, Pfizer, CombiMatrix, Sigma-Tau Pharmaceuticals.....

    Nanomedicines – Global Market Demand, Growth, Opportunities, Manufacturers, Analysis of Top Key Players and Forecast to 2025 Posted via Industry Today. Follow us on Twitter @IndustryToday
    Show more
    Report incorrect company information

    Johnson & Johnson Company Life and Culture

    Report incorrect company information
    Download PDF